Indraprastha Medical Valuation

Is INDRAMEDCO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of INDRAMEDCO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: INDRAMEDCO (₹415.9) is trading above our estimate of fair value (₹211.54)

Significantly Below Fair Value: INDRAMEDCO is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for INDRAMEDCO?

Key metric: As INDRAMEDCO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for INDRAMEDCO. This is calculated by dividing INDRAMEDCO's market cap by their current earnings.
What is INDRAMEDCO's PE Ratio?
PE Ratio	25.8x
Earnings	₹1.48b
Market Cap	₹38.13b

INDRAMEDCO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.7x
Enterprise Value/EBITDA	15.8x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does INDRAMEDCO's PE Ratio compare to its peers?

The above table shows the PE ratio for INDRAMEDCO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	63.4x
ARTEMISMED Artemis Medicare Services	68.1x	35.1%	₹44.1b
523323 Kovai Medical Center and Hospital	28.6x	n/a	₹57.7b
SHALBY Shalby	42.4x	59.6%	₹23.2b
HCG HealthCare Global Enterprises	114.4x	48.2%	₹65.3b
INDRAMEDCO Indraprastha Medical	25.8x	n/a	₹38.1b

Price-To-Earnings vs Peers: INDRAMEDCO is good value based on its Price-To-Earnings Ratio (25.8x) compared to the peer average (63.4x).

Price to Earnings Ratio vs Industry

How does INDRAMEDCO's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.1x	n/a	US$11.77m
542918 Gian Life Care	4.8x	n/a	US$2.28m

No more companies available in this PE range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: INDRAMEDCO is good value based on its Price-To-Earnings Ratio (25.8x) compared to the Indian Healthcare industry average (42.6x).

Price to Earnings Ratio vs Fair Ratio

What is INDRAMEDCO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

INDRAMEDCO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	25.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate INDRAMEDCO's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹612.9m

Trades in pharmaceutical products.

539938

₹61.29

33.1%

-27.8%

Mohini Health & Hygiene

₹911.8m

Engages in the manufacture and sale of health and hygiene products in India.

MHHL

₹50.00

-0.9%

-25.3%

Dr Lalchandani Labs

₹81.2m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.73

4.1%

-46.5%